Lexington, Ky. – US Equestrian (USEF) and American Regent Animal Health, a division of American Regent, Inc. and the manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan), are proud to announce that Adequan® i.m. will continue its sponsorship with US Equestrian as an Official Partner and Official Joint Therapy Product through November 30, 2022.
In addition to its official sponsor designations, Adequan® i.m. will continue as the title sponsor of the Adequan FEI North American Youth Championships (NAYC) presented by Gotham North, rebranded in 2018 with a fresh face and new name. American Regent Animal Health’s support of the NAYC will continue to further the championships’ goal of promoting and encouraging team and individual competition in these international disciplines. In 2019, the NAYC for eventing will be held at Rebecca Farm in Kalispell, Mont., July 25-28, while the NAYC for dressage and jumping will be held at Old Salem Farm in North Salem, N.Y., July 30 – August 4.
In addition, USEF has granted Adequan the following new designations:
- Adequan U.S. Para-Equestrian Dressage Team,
- Adequan USEF Para-Equestrian Dressage National Championships, and
- 2019 US Equestrian Annual Meeting Pegasus Dinner, presented by Adequan
“Adequan is a longtime sponsor and partner of USEF and equestrian sport in the U.S., including para-dressage and our nation’s youth athletes,” said US Equestrian CEO Bill Moroney. “We are thrilled that they have chosen to extend their title sponsorship of NAYC and expand this to our para-equestrian dressage team and national championships. Their support contributes greatly to these athletes’ and their horses’ success both at home and on the international stage.”
“US Equestrian is one of our longest-standing partnerships, and we are especially proud to be part of the youth program,” said Allyn Mann, Director of Strategic Partnerships for American Regent Animal Health. “These young riders represent the future of the equine industry and it is our privilege to help protect the health of their amazing equine athletes. We are equally honored to add our support to the para-equestrian dressage team as their stories and accomplishments continue to awe and inspire us.”
About Adequan® i.m. (polysulfated glycosaminoglycan or PSGAG)
Adequan® i.m. is indicated for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. Adequan® i.m. is the only FDA-approved PSGAG which has been proven to help improve joint function by reversing the disease cycle, repairing cartilage, restoring joint lubrication and reducing inflammation., Ask your veterinarian if Adequan® i.m. is the right choice for your horse.
IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For more information and Full Prescribing Information, visit www.adequan.com.
About American Regent Animal Health
American Regent Animal Health, formerly known as Luitpold Animal Health, is a division of American Regent, Inc. American Regent Animal Health is committed to advancing animal health with proven FDA-approved products like Adequan®. The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio under the American Regent brand. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.
For more information on becoming a USEF sponsor, please contact Layson Griffin at [email protected] or 859-225-6942.
1Burba DJ, Collier MA, DeBault LE, Hanson-Painton O, Thompson HC, Holder CL: In vivo kinetic study on uptake and distribution of intramuscular tritium-labeled polysulfated glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteochondral defect model. J Equine Vet Sci 1993; 13: 696-703.
2Adequan® i.m. Package Insert, Rev 1/19.